Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- CORPORATE ROUNDUP NEWS IN BRIEF
September 17, 2001
- DIAGNOSTIC NEWS IN BRIEF
September 17, 2001
- Healthcare Reform: 30% Copayment for the Insured to Be Focused on
September 17, 2001
- Thorough Quality Control for Imported Medical Devices Called For by PMSB
September 17, 2001
- Hodanren Opposes Raising the Age Limit to 75 for Elderly Healthcare Services
September 17, 2001
- PMSB Budget Related to Medical Devices Focuses on Quality, Prioritization of Review
September 17, 2001
- 3 New Drugs Including Biapenem Recommended for Approval
September 17, 2001
- Enforcement of US/EC MRA Expected to Be Delayed: FDA Officer
September 17, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
September 10, 2001
- METI Demands \1,015.1 Bil., Up 9.09%
September 10, 2001
- Clinical Study to Collect Data on Ethnic Differences Completed
September 10, 2001
- Monkasho Demands \91,023 Mil. to Promote Life Science
September 10, 2001
- Fosamac Reduces Multiple New Fracture Risk by up to 70% in Osteoporosis: Banyu Seminar
September 10, 2001
- Korosho Demands Budget of \18,745.5 Bil. for FY2002, Up 3.63%
September 10, 2001
- Combination of Thrombolytic, Cerebral Protective Agents Recommended for CI: MTP Seminar
September 10, 2001
- Korosho to Propose Healthcare System Reform at End of Sept.
September 10, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 10, 2001
- Goal Is 5 Years from Development to Approval: PMSB
September 10, 2001
- Latest Information Cannot Be Diffused Through Package Inserts: Seminar
September 10, 2001
- Bill for Revision of PAL to Be Submitted Next Diet Session
September 10, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…